Long non-coding RNAs engender drug resistance to different subtypes of treatments of breast cancers and may provide a "next generation" therapy option.

In conclusion, lncRNAs molecules may represent the "next generation" therapy option for breast cancer patients.
PMID: 32598860 [PubMed - in process]

Source: Discovery Medicine - July 1, 2020 Category: Research Tags: Discov Med Source Type: research